|
1
|
Ichikawa T, Sano K and Morisaka H:
Diagnosis of pathologically early HCC with EOB-MRI: Experiences and
current consensus. Liver Cancer. 3:97–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wei KR, Yu X, Zheng RS, Peng XB, Zhang SW,
Ji MF, Liang ZH, Ou ZX and Chen WQ: Incidence and mortality of
liver cancer in China, 2010. Chin J Cancer. 33:388–394.
2014.PubMed/NCBI
|
|
3
|
Ringelhan M, O'Connor T, Protzer U and
Heikenwalder M: The direct and indirect roles of HBV in liver
cancer: prospective markers for HCC screening and potential
therapeutic targets. J Pathol. 235:355–367. 2015. View Article : Google Scholar
|
|
4
|
de Lope CR, Tremosini S, Forner A, Reig M
and Bruix J: Management of HCC. J Hepatol. 56(Suppl 1): S75–S87.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Finn RS: Advanced HCC: Emerging molecular
therapies. Minerva Gastroenterol Dietol. 58:25–34. 2012.PubMed/NCBI
|
|
6
|
Brodersen P, Sakvarelidze-Achard L,
Bruun-Rasmussen M, Dunoyer P, Yamamoto YY, Sieburth L and Voinnet
O: Widespread translational inhibition by plant miRNAs and siRNAs.
Science. 320:1185–1190. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Anwar SL and Lehmann U: MicroRNAs:
emerging novel clinical biomarkers for hepatocellular carcinomas. J
Clin Med. 4:1631–1650. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calin GA, Cimmino A, Fabbri M, Ferracin M,
Wojcik SE, Shimizu M, Taccioli C, Zanesi N, Garzon R, Aqeilan RI,
et al: MiR-15a and miR-16-1 cluster functions in human leukemia.
Proc Natl Acad Sci USA. 105:5166–5171. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu G, Yu F, Xiao Z, Xu K, Xu J, Tang W,
Wang J and Song E: Hepatitis B virus X protein downregulates
expression of the miR-16 family in malignant hepatocytes in vitro.
Br J Cancer. 105:146–153. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Renjie W and Haiqian L: MiR-132, miR-15a
and miR-16 syner-gistically inhibit pituitary tumor cell
proliferation, invasion and migration by targeting Sox5. Cancer
Lett. 356B:568–578. 2015. View Article : Google Scholar
|
|
11
|
Shi L, Jackstadt R, Siemens H, Li H,
Kirchner T and Hermeking H: p53-induced miR-15a/16-1 and AP4 form a
double-negative feedback loop to regulate epithelial-mesenchymal
transition and metastasis in colorectal cancer. Cancer Res.
74:532–542. 2014. View Article : Google Scholar
|
|
12
|
Wang Q, Li X, Zhu Y and Yang P:
MicroRNA-16 suppresses epithelial-mesenchymal transition-related
gene expression in human glioma. Mol Med Rep. 10:3310–3314.
2014.PubMed/NCBI
|
|
13
|
Zhang LY, Liu M, Li X and Tang H:
miR-490-3p modulates cell growth and epithelial to mesenchymal
transition of hepatocellular carcinoma cells by targeting
endoplasmic reticulum-Golgi intermediate compartment protein 3
(ERGIC3). J Biol Chem. 288:4035–4047. 2013. View Article : Google Scholar :
|
|
14
|
Dai XF, Ding J, Zhang RG, Ren JH, Ma CM
and Wu G: Radio-sensitivity enhancement of human hepatocellular
carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK
signal pathway. Int J Radiat Biol. 89:724–731. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tian T, Nan KJ, Guo H, Wang WJ, Ruan ZP,
Wang SH, Liang X and Lu CX: PTEN inhibits the migration and
invasion of HepG2 cells by coordinately decreasing MMP expression
via the PI3K/Akt pathway. Oncol Rep. 23:1593–1600. 2010.PubMed/NCBI
|
|
16
|
Xiang Q, Ma Y, Dong J and Shen R: Carnosic
acid induces apoptosis associated with mitochondrial dysfunction
and Akt inactivation in HepG2 cells. Int J Food Sci Nutr. 66:76–84.
2015. View Article : Google Scholar
|
|
17
|
Tsai JH, Hsu LS, Lin CL, Hong HM, Pan MH,
Way TD and Chen WJ: 3,5,4′-Trimethoxystilbene, a natural
methoxylated analog of resveratrol, inhibits breast cancer cell
invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin
signaling cascades and reversal of epithelial-mesenchymal
transition. Toxicol Appl Pharmacol. 272:746–756. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nagasawa T, Matsushima-Nishiwaki R, Toyoda
H, Matsuura J, Kumada T and Kozawa O: Heat shock protein 20 (HSPB6)
regulates apoptosis in human hepatocellular carcinoma cells: Direct
association with Bax. Oncol Rep. 32:1291–1295. 2014.PubMed/NCBI
|
|
19
|
Zhao N, Sun BC, Zhao XL, Wang Y, Sun HZ,
Dong XY, Meng J and Gu Q: Changes in microRNAs associated with
Twist-1 and Bcl-2 overexpression identify signaling pathways. Exp
Mol Pathol. 99:524–532. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chamorro-Jorganes A, Araldi E, Penalva LO,
Sandhu D, Fernández-Hernando C and Suárez Y: MicroRNA-16 and
microRNA-424 regulate cell-autonomous angiogenic functions in
endothelial cells via targeting vascular endothelial growth factor
receptor-2 and fibroblast growth factor receptor-1. Arterioscler
Thromb Vasc Biol. 31:2595–2606. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Goretti E, Rolland-Turner M, Léonard F,
Zhang L, Wagner DR and Devaux Y: MicroRNA-16 affects key functions
of human endothelial progenitor cells. J Leukoc Biol. 93:645–655.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bhattacharya R, Nicoloso M, Arvizo R, Wang
E, Cortez A, Rossi S, Calin GA and Mukherjee P: MiR-15a and MiR-16
control Bmi-1 expression in ovarian cancer. Cancer Res.
69:9090–9095. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tang R, Cui ZM and Lou YH: MicroRNA-16
regulates the proliferation, invasion and apoptosis of ovarian
epithelial carcinoma cells in vitro. Zhonghua Fu Chan Ke Za Zhi.
47:846–850. 2012.In Chinese.
|
|
25
|
Yang TQ, Lu XJ, Wu TF, Ding DD, Zhao ZH,
Chen GL, Xie XS, Li B, Wei YX, Guo LC, et al: MicroRNA-16 inhibits
glioma cell growth and invasion through suppression of BCL2 and the
nuclear factor-κB1/MMP9 signaling pathway. Cancer Sci. 105:265–271.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ordoñez R, Carbajo-Pescador S,
Prieto-Dominguez N, García-Palomo A, González-Gallego J and Mauriz
JL: Inhibition of matrix metalloproteinase-9 and nuclear factor
kappa B contribute to melatonin prevention of motility and
invasiveness in HepG2 liver cancer cells. J Pineal Res. 56:20–30.
2014. View Article : Google Scholar
|
|
27
|
Zhang Y, Shen Y, Cao B, Yan A and Ji H:
Elevated expression levels of androgen receptors and matrix
metalloproteinase-2 and -9 in 30 cases of hepatocellular carcinoma
compared with adjacent tissues as predictors of cancer invasion and
staging. Exp Ther Med. 9:905–908. 2015.PubMed/NCBI
|
|
28
|
Ogunwobi OO and Liu C: Therapeutic and
prognostic importance of epithelial-mesenchymal transition in liver
cancers: Insights from experimental models. Crit Rev Oncol Hematol.
83:319–328. 2012. View Article : Google Scholar
|
|
29
|
Yang JD, Nakamura I and Roberts LR: The
tumor microenvironment in hepatocellular carcinoma: Current status
and therapeutic targets. Semin Cancer Biol. 21:35–43. 2011.
View Article : Google Scholar :
|
|
30
|
Hou KZ, Fu ZQ and Gong H: Chemokine ligand
20 enhances progression of hepatocellular carcinoma via
epithelial-mesen-chymal transition. World J Gastroenterol.
21:475–483. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yamada S, Okumura N, Wei L, Fuchs BC,
Fujii T, Sugimoto H, Nomoto S, Takeda S, Tanabe KK and Kodera Y:
Epithelial to mesenchymal transition is associated with shorter
disease-free survival in hepatocellular carcinoma. Ann Surg Oncol.
21:3882–3890. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhai X, Zhu H, Wang W, Zhang S, Zhang Y
and Mao G: Abnormal expression of EMT-related proteins, S100A4,
vimentin and E-cadherin, is correlated with clinicopathological
features and prognosis in HCC. Med Oncol. 31:9702014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang H and Zhou Q: E-cadherin/beta-catenin
and the invasion and metastasis of lung cancer. Zhongguo Fei Ai Za
Zhi. 13:254–259. 2010.In Chinese. PubMed/NCBI
|
|
34
|
Wang TH, Lin YS, Chen Y, Yeh CT, Huang YL,
Hsieh TH, Shieh TM, Hsueh C and Chen TC: Long non-coding RNA AOC4P
suppresses hepatocellular carcinoma metastasis by enhancing
vimentin degradation and inhibiting epithelial-mesenchymal
transition. Oncotarget. 6:23342–23357. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou Q, Lui VW and Yeo W: Targeting the
PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Future Oncol.
7:1149–1167. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lang Q and Ling C: MiR-124 suppresses cell
proliferation in hepatocellular carcinoma by targeting PIK3CA.
Biochem Biophys Res Commun. 426:247–252. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yan H, Wang S, Yu H, Zhu J and Chen C:
Molecular pathways and functional analysis of miRNA expression
associated with paclitaxel-induced apoptosis in hepatocellular
carcinoma cells. Pharmacology. 92:167–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chetty C, Lakka SS, Bhoopathi P and Rao
JS: MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated
PI3K/AKT signaling in A549 lung cancer cells. Int J Cancer.
127:1081–1095. 2010. View Article : Google Scholar :
|
|
39
|
Shan RF, Zhou YF, Peng AF and Jie ZG:
Inhibition of Aurora-B suppresses HepG2 cell invasion and migration
via the PI3K/Akt/NF-κB signaling pathway in vitro. Exp Ther Med.
8:1005–1009. 2014.PubMed/NCBI
|
|
40
|
Xu L, Zhang Y, Wang H, Zhang G, Ding Y and
Zhao L: Tumor suppressor miR-1 restrains epithelial-mesenchymal
transition and metastasis of colorectal carcinoma via the MAPK and
PI3K/AKT pathway. J Transl Med. 12:2442014. View Article : Google Scholar : PubMed/NCBI
|
